A retrospective study by Kang et al. [79] in Korean pediatric patients with IBD offers a more detailed understanding by correlating the NUDT15 metabolizer status (normal, intermediate, and poor metabolizers) to time-to-leucopenia and suggesting lower 6-TGN targets to intermediate metabolizers. This evidence concerns the gene NUDT15 and inflammatory bowel disease.